| Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression DS Basseres, AS Baldwin Oncogene 25 (51), 6817-6830, 2006 | 853 | 2006 |
| Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations HS Radomska, DS Bassères, R Zheng, P Zhang, T Dayaram, ... The Journal of experimental medicine 203 (2), 371-381, 2006 | 239 | 2006 |
| Requirement of the NF-κB subunit p65/RelA for K-Ras–induced lung tumorigenesis DS Bassères, A Ebbs, E Levantini, AS Baldwin Cancer research 70 (9), 3537-3546, 2010 | 236 | 2010 |
| Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα) HC Dan, A Ebbs, M Pasparakis, T Van Dyke, DS Basseres, AS Baldwin Journal of Biological Chemistry 289 (36), 25227-25240, 2014 | 158 | 2014 |
| A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3β as a novel tumor suppressor in lung cancer B Halmos, DS Basseres, S Monti, F D ‘Aló, T Dayaram, K Ferenczi, ... Cancer research 64 (12), 4137-4147, 2004 | 93 | 2004 |
| Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPα in mice DS Basseres, E Levantini, H Ji, S Monti, S Elf, T Dayaram, M Fenyus, ... Molecular and cellular biology 26 (3), 1109-1123, 2006 | 77 | 2006 |
| ARHGAP10, a novel human gene coding for a potentially cytoskeletal Rho-GTPase activating protein DS Bassères, EV Tizzei, AAS Duarte, FF Costa, STO Saad Biochemical and biophysical research communications 294 (3), 579-585, 2002 | 75 | 2002 |
| Mutation analysis of the HFE gene in Brazilian populations MF Agostinho, VR Arruda, DS Basseres, S Bordin, MCP Soares, ... Blood Cells, Molecules, and Diseases 25 (6), 324-327, 1999 | 69 | 1999 |
| Human leukocyte formin: a novel protein expressed in lymphoid malignancies and associated with Akt PMB Favaro, S de Souza Medina, F Traina, DS Basseres, FF Costa, ... Biochemical and biophysical research communications 311 (2), 365-371, 2003 | 60 | 2003 |
| Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression KJ Yong, DS Basseres, RS Welner, WC Zhang, H Yang, B Yan, ... Science translational medicine 8 (350), 350ra104-350ra104, 2016 | 58 | 2016 |
| Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing DS Basseres, F D’Alò, BY Yeap, EC Löwenberg, DA Gonzalez, H Yasuda, ... Lung cancer 77 (1), 31-37, 2012 | 56 | 2012 |
| Ca2+-dependent permeabilization of the inner mitochondrial membrane by 4, 4′-diisothiocyanatostilbene-2, 2′-disulfonic acid (DIDS) CF Bernardes, JR Meyer-Fernandes, DS Basseres, RF Castilho, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1188 (1-2), 93-100, 1994 | 55 | 1994 |
| IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity DS Bassères, A Ebbs, PC Cogswell, AS Baldwin Genes & cancer 5 (1-2), 41, 2014 | 52 | 2014 |
| Aurora kinase targeting in lung cancer reduces KRAS-induced transformation EO Dos Santos, TC Carneiro-Lobo, MN Aoki, E Levantini, DS Bassères Molecular cancer 15, 1-14, 2016 | 50 | 2016 |
| Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment JK Valenzuela-Oses, MC Garcia, VA Feitosa, JA Pachioni-Vasconcelos, ... Materials Science and Engineering: C 81, 327-333, 2017 | 47 | 2017 |
| Novel mutation in theMYOC gene in primary open angle glaucoma patients JPC Vasconcellos, MB Melo, VP Costa, DML Tsukumo, DS BASSÈRES, ... Journal of Medical Genetics 37 (4), 301-303, 2000 | 43 | 2000 |
| RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element E Levantini, S Lee, HS Radomska, CJ Hetherington, M Alberich‐Jorda, ... The EMBO journal 30 (19), 4059-4070, 2011 | 40 | 2011 |
| Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer SM Gomes-Filho, EO Dos Santos, ERM Bertoldi, LC Scalabrini, ... Cellular Oncology 43, 445-460, 2020 | 34 | 2020 |
| Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression PG Gallagher, DE Sabatino, DS Basseres, DM Nilson, C Wong, AP Cline, ... Journal of Biological Chemistry 276 (45), 41683-41689, 2001 | 31 | 2001 |
| Low frequency of ankyrin mutations in hereditary spherocytosis: identification of three novel mutations RCA Leite, DS Basseres, JS Ferreira, FL Alberto, FF Costa, STO Saad Human mutation 16 (6), 529-529, 2000 | 27 | 2000 |
